Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Part Fibre Toxicol ; 20(1): 43, 2023 Nov 17.
Article in English | MEDLINE | ID: mdl-37978398

ABSTRACT

BACKGROUND: Metallic nanoparticles (NPs) are widely used as food additives for human consumption. NPs reach the bloodstream given their small size, getting in contact with all body organs and cells. NPs have adverse effects on the respiratory and intestinal tract; however, few studies have focused on the toxic consequences of orally ingested metallic NPs on the cardiovascular system. Here, the effects of two food-grade additives on the cardiovascular system were analyzed. METHODS: Titanium dioxide labeled as E171 and zinc oxide (ZnO) NPs were orally administered to Wistar rats using an esophageal cannula at 10 mg/kg bw every other day for 90 days. We evaluated cardiac cell morphology and death, expression of apoptotic and autophagic proteins in cardiac mitochondria, mitochondrial dysfunction, and concentration of metals on cardiac tissue. RESULTS: Heart histology showed important morphological changes such as presence of cellular infiltrates, collagen deposition and mitochondrial alterations in hearts from rats exposed to E171 and ZnO NPs. Intracellular Cyt-C levels dropped, while TUNEL positive cells increased. No significant changes in the expression of inflammatory cytokines were detected. Both NPs altered mitochondrial function indicating cardiac dysfunction, which was associated with an elevated concentration of calcium. ZnO NPs induced expression of caspases 3 and 9 and two autophagic proteins, LC3B and beclin-1, and had the strongest effect compared to E171. CONCLUSIONS: E171 and ZnO NPs induce adverse cardiovascular effects in rats after 90 days of exposure, thus food intake containing these additives, should be taken into consideration, since they translocate into the bloodstream and cause cardiovascular damage.


Subject(s)
Metal Nanoparticles , Nanoparticles , Zinc Oxide , Rats , Humans , Animals , Zinc Oxide/toxicity , Rats, Wistar , Nanoparticles/toxicity , Heart , Metal Nanoparticles/toxicity , Titanium/toxicity , Food Additives/toxicity
2.
Int J Mol Sci ; 24(6)2023 Mar 10.
Article in English | MEDLINE | ID: mdl-36982395

ABSTRACT

Metabolic syndrome (MetS) is a cluster of factors that increase the risk of developing diabetes, stroke, and heart failure. The pathophysiology of injury by ischemia/reperfusion (I/R) is highly complex and the inflammatory condition plays an important role by increasing matrix remodeling and cardiac apoptosis. Natriuretic peptides (NPs) are cardiac hormones with numerous beneficial effects mainly mediated by a cell surface receptor named atrial natriuretic peptide receptor (ANPr). Although NPs are powerful clinical markers of cardiac failure, their role in I/R is still controversial. Peroxisome proliferator-activated receptor α agonists exert cardiovascular therapeutic actions; however, their effect on the NPs' signaling pathway has not been extensively studied. Our study provides important insight into the regulation of both ANP and ANPr in the hearts of MetS rats and their association with the inflammatory conditions caused by damage from I/R. Moreover, we show that pre-treatment with clofibrate was able to decrease the inflammatory response that, in turn, decreases myocardial fibrosis, the expression of metalloprotease 2 and apoptosis. Treatment with clofibrate is also associated with a decrease in ANP and ANPr expression.


Subject(s)
Metabolic Syndrome , Reperfusion Injury , Rats , Animals , Atrial Natriuretic Factor/metabolism , PPAR alpha/agonists , Clofibrate/pharmacology , Metabolic Syndrome/complications , Metabolic Syndrome/drug therapy , Reperfusion Injury/drug therapy , Reperfusion Injury/metabolism , Receptors, Atrial Natriuretic Factor/metabolism , Natriuretic Peptides , Ischemia , Arrhythmias, Cardiac , Inflammation/drug therapy
3.
Korean J Physiol Pharmacol ; 26(2): 77-86, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-35203058

ABSTRACT

The effect of PHAR-DBH-Me, a cannabinoid receptor agonist, on different cardiovascular responses in adult male rats was analyzed. The blood pressure was measured directly and indirectly. The coronary flow was measured by Langendorff preparation, and vasomotor responses induced by PHAR-DBH-Me in aortic rings precontracted with phenylephrine (PHEN) were analyzed. The intravenous injection of the compound PHAR-DBH-Me (0.018-185 µg/kg) resulted in decreased blood pressure; maximum effect was observed at the dose of 1,850 µg/kg. A concentration-dependent increase in the coronary flow was observed in a Langendorff preparation. In the aortic rings, with and without endothelium, pre-contracted with PHEN (10-6 M), the addition of PHAR-DBH-Me to the superfusion solution (10-12-10-5 M), produced a vasodilator response, which depends on the concentration and presence of the endothelium. L-NAME inhibited these effects. Addition of CB1 receptor antagonist (AM 251) did not modify the response, while CB2 receptor antagonist (AM630) decreased the potency of relaxation elicited by PHAR-DBH-Me. Indomethacin shifted the curve concentration-response to the left and produced an increase in the magnitude of the maximum endothelium dependent response to this compound. The maximum effect of PHAR-DBH-Me was observed with the concentration of 10-5 M. These results show that PHAR-DBH-Me has a concentration-dependent and endothelium-dependent vasodilator effect through CB2 receptor. This vasodilation is probably mediated by the synthesis/release of NO. On the other hand, it is suggested that PHAR-DBH-Me also induces the release of a vasoconstrictor prostanoid.

4.
Pediatr Blood Cancer ; 67(11): e28679, 2020 11.
Article in English | MEDLINE | ID: mdl-32860659

ABSTRACT

Composite sarcoma of bone is a very rare entity that primarily affects adolescent and young adult patients. It usually combines areas of liposarcoma and osteosarcoma, and up to 60% of cases have metastatic disease at diagnosis. It is a highly aggressive pathology with intrinsic resistance to bone sarcoma conventional treatments. The prognosis is poor, with long-term survival rates not exceeding 30%. We present the case of an adolescent female diagnosed with an aggressive composite sarcoma of bone with rhabdomyosarcoma foci and loco-regional lymph node involvement.


Subject(s)
Bone Neoplasms/secondary , Osteosarcoma/secondary , Rhabdomyosarcoma/pathology , Soft Tissue Neoplasms/secondary , Adolescent , Bone Neoplasms/surgery , Female , Humans , Lymphatic Metastasis , Osteosarcoma/surgery , Prognosis , Rhabdomyosarcoma/surgery , Soft Tissue Neoplasms/surgery
5.
Biochem Cell Biol ; 97(2): 187-192, 2019 04.
Article in English | MEDLINE | ID: mdl-30332552

ABSTRACT

In the kidney, the accumulation of heavy metals such as Cd2+ produces mitochondrial dysfunctions, i.e., uncoupling of the oxidative phosphorylation, inhibition of the electron transport through the respiratory chain, and collapse of the transmembrane electrical gradient. This derangement may be due to the fact that Cd2+ induces the transition of membrane permeability from selective to nonselective via the opening of a transmembrane pore. In fact, Cd2+ produces this injury through the stimulation of oxygen-derived radical generation, inducing oxidative stress. Several molecules have been used to avoid or even reverse Cd2+-induced mitochondrial injury, for instance, cyclosporin A, resveratrol, dithiocarbamates, and even EDTA. The aim of this study was to explore the possibility that the antioxidant tamoxifen could protect mitochondria from the deleterious effects of Cd2+. Our results indicate that the addition of 1 µmol/L Cd2+ to mitochondria collapsed the transmembrane electrical gradient, induced the release of cytochrome c, and increased both the generation of H2O2 and the oxidative damage to mitochondrial DNA (among other measured parameters). Of interest, these mitochondrial dysfunctions were ameliorated after the addition of tamoxifen.


Subject(s)
Cadmium/toxicity , Hydrogen Peroxide/metabolism , Kidney/metabolism , Membrane Potential, Mitochondrial/drug effects , Mitochondria/metabolism , Oxidative Stress/drug effects , Animals , Kidney/pathology , Mitochondria/pathology , Oxidation-Reduction/drug effects
6.
Molecules ; 24(2)2019 Jan 12.
Article in English | MEDLINE | ID: mdl-30642049

ABSTRACT

Myocardial infarction (MI) initiates an inflammatory response that promotes both beneficial and deleterious effects. The early response helps the myocardium to remove damaged tissue; however, a prolonged later response brings cardiac remodeling characterized by functional, metabolic, and structural pathological changes. Current pharmacological treatments have failed to reverse ischemic-induced cardiac damage. Therefore, our aim was to study if clofibrate treatment was capable of decreasing inflammation and apoptosis, and reverse ventricular remodeling and MI-induced functional damage. Male Wistar rats were assigned to (1) Sham coronary artery ligation (Sham) or (2) Coronary artery ligation (MI). Seven days post-MI, animals were further divided to receive vehicle (V) or clofibrate (100 mg/kg, C) for 7 days. The expression of IL-6, TNF-α, and inflammatory related molecules ICAM-1, VCAM-1, MMP-2 and -9, nuclear NF-kB, and iNOS, were elevated in MI-V. These inflammatory biomarkers decreased in MI-C. Also, apoptotic proteins (Bax and pBad) were elevated in MI-V, while clofibrate augmented anti-apoptotic proteins (Bcl-2 and 14-3-3ε). Clofibrate also protected MI-induced changes in ultra-structure. The ex vivo evaluation of myocardial functioning showed that left ventricular pressure and mechanical work decreased in infarcted rats; clofibrate treatment raised those parameters to control values. Echocardiogram showed that clofibrate partially reduced LV dilation. In conclusion, clofibrate decreases cardiac remodeling, decreases inflammatory molecules, and partly preserves myocardial diameters.


Subject(s)
Clofibrate/pharmacology , Hypolipidemic Agents/pharmacology , Inflammation/pathology , Myocardial Infarction/drug therapy , Myocardial Infarction/pathology , Ventricular Remodeling/drug effects , Animals , Cytokines/metabolism , Disease Models, Animal , Inflammation/metabolism , Inflammation Mediators/metabolism , Myocardial Infarction/metabolism , PPAR alpha/metabolism , Rodentia
7.
Liver Transpl ; 24(8): 1070-1083, 2018 08.
Article in English | MEDLINE | ID: mdl-29679463

ABSTRACT

Cytidine-5'-diphosphocholine (CDP-choline) participates as an intermediary in the synthesis of phosphatidylcholine, an essential component of cellular membranes. Citicoline treatment has shown beneficial effects in cerebral ischemia, but its potential to diminish reperfusion damage in liver has not been explored. In this work, we evaluated the hepatoprotective effect of citicoline and its possible association with inflammatory/oxidative stress and mitochondrial function because they are the main cellular features of reperfusion damage. Ischemia/reperfusion (I/R) in rat livers was performed with the Pringle's maneuver, clamping the 3 elements of the pedicle (hepatic artery, portal vein, and biliary tract) for 30 minutes and then removing the clamp to allow hepatic reperfusion for 60 minutes. The I/R + citicoline group received the compound before I/R. Liver injury was evaluated by measuring aspartate aminotransferase and alanine aminotransferase as well as lactic acid levels in serum; proinflammatory cytokines, proresolving lipid mediators, and nuclear factor kappa B content were determined as indicators of the inflammatory response. Antioxidant effects were evaluated by measuring markers of oxidative stress and antioxidant molecules. Oxygen consumption and the activities of the respiratory chain were used to monitor mitochondrial function. CDP-choline reduced aspartate aminotransferase (AST), alanine aminotransferase (ALT), as well as lactic acid levels in blood samples from reperfused rats. Diminution in tumor necrosis factor alpha (TNF-α) and increase in the proresolving lipid mediator resolvin D1 were also observed in the I/R+citicoline group, in comparison with the I/R group. Oxidative/nitroxidative stress in hepatic mitochondria concurred with deregulation of oxidative phosphorylation, which was associated with the loss of complex III and complex IV activities. In conclusion, CDP-choline attenuates liver damage caused by ischemia and reperfusion by reducing oxidative stress and maintaining mitochondrial function. Liver Transplantation XX XX-XX 2018 AASLD.


Subject(s)
Cytidine Diphosphate Choline/pharmacology , Liver Transplantation/adverse effects , Mitochondria/drug effects , Protective Agents/pharmacology , Reperfusion Injury/prevention & control , Animals , Cytidine Diphosphate Choline/therapeutic use , Disease Models, Animal , Humans , Liver/cytology , Liver/drug effects , Liver/pathology , Liver/surgery , Liver Function Tests , Male , Mitochondria/metabolism , Oxidative Stress/drug effects , Protective Agents/therapeutic use , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Reperfusion Injury/etiology , Reperfusion Injury/pathology
8.
Biochem Cell Biol ; 95(2): 310-317, 2017 04.
Article in English | MEDLINE | ID: mdl-28177775

ABSTRACT

For malaria transmission, Plasmodium parasites must develop in the mosquito vector. Oxidative stress in the insect midgut, triggered by environmental changes (e.g., pH and temperature), influences the cellular signaling involved in differentiation from gametocytes to mobile ookinetes for the purpose of parasite survival. Oxidative stress activates the homeostatic response to stress characterized by the phosphorylation eIF2α, the attenuation of protein synthesis, and the transcription of genes participating in the unfolded protein response and antioxidant processes, forming a part of an integrated stress response (ISR). We hypothesized that ISR operates during the differentiation of gametocytes to ookinetes to assure Plasmodium survival. Using in-vitro conditions resembling the mosquito midgut conditions, we cultured Plasmodium berghei gametocytes to ookinetes and evaluated the redox balance by detecting reactive oxygen species and superoxide dismutase activity. Additionally, we evaluated the phosphorylation of eIF2α, the attenuation of the global protein synthesis, and the gene expression of cellular stress markers (e.g., endoplasmic reticulum chaperones and antioxidant molecules, measured by reverse-transcription quantitative polymerase chain reaction), finding that these processes were all taking place, probably to improve survival during the differentiation of Plasmodium berghei ookinetes.


Subject(s)
Erythrocytes/parasitology , Eukaryotic Initiation Factor-2/genetics , Life Cycle Stages/genetics , Plasmodium berghei/genetics , Protozoan Proteins/genetics , Reactive Oxygen Species/metabolism , Animals , Cell Differentiation , Endoplasmic Reticulum Chaperone BiP , Eukaryotic Initiation Factor-2/metabolism , Gene Expression Regulation , Heat-Shock Proteins/genetics , Heat-Shock Proteins/metabolism , Host-Parasite Interactions , Malaria/parasitology , Mice , Mice, Inbred BALB C , Models, Biological , Oxidative Stress , Peroxiredoxins/genetics , Peroxiredoxins/metabolism , Phosphorylation , Plasmodium berghei/growth & development , Plasmodium berghei/metabolism , Primary Cell Culture , Protein Disulfide-Isomerases/genetics , Protein Disulfide-Isomerases/metabolism , Protozoan Proteins/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Unfolded Protein Response
9.
Biochem Cell Biol ; 95(5): 556-562, 2017 10.
Article in English | MEDLINE | ID: mdl-28595020

ABSTRACT

In this work, we studied the protective effects of tamoxifen (TAM) on disulfiram (Dis)-induced mitochondrial membrane insult. The results indicate that TAM circumvents the inner membrane leakiness manifested as Ca2+ release, mitochondrial swelling, and collapse of the transmembrane electric gradient. Furthermore, it was found that TAM prevents inactivation of the mitochondrial enzyme aconitase and detachment of cytochrome c from the inner membrane. Interestingly, TAM also inhibited Dis-promoted generation of hydrogen peroxide. Given that TAM is an antioxidant molecule, it is plausible that its protection may be due to the inhibition of Dis-induced oxidative stress.


Subject(s)
Disulfiram/adverse effects , Mitochondrial Membranes/drug effects , Tamoxifen/pharmacology , Animals , Calcium/metabolism , Mitochondrial Membranes/metabolism , Mitochondrial Membranes/pathology , Oxidative Stress/drug effects , Rats , Rats, Wistar
10.
Cell Biol Int ; 41(12): 1356-1366, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28884894

ABSTRACT

Heavy metal ions are known to produce harmful alterations on kidney function. Specifically, the accumulation of Hg2+ in kidney tissue may induce renal failure. In this work, the protective effect of CDP-choline against the deleterious effects induced by Hg2+ on renal function was studied. CDP-choline administered ip at a dose of 125 mg/kg body weight prevented the damage induced by Hg2+ administration at a dose of 3 mg/kg body weight. The findings indicate that CDP-choline guards mitochondria against Hg2+ -toxicity by preserving their ability to retain matrix content, such as accumulated Ca2+ . This nucleotide also protected mitochondria from Hg2+ -induced loss of the transmembrane electric gradient and from the generation of hydrogen peroxide and membrane TBARS. In addition, CDP-choline avoided the oxidative damage of mtDNA and inhibited the release of the interleukins IL-1 and IL6, recognized as markers of acute inflammatory reaction. After the administration of Hg2+ and CDP, CDP-choline maintained nearly normal levels of renal function and creatinine clearance, as well as blood urea nitrogen (BUN) and serum creatinine.


Subject(s)
Cytidine Diphosphate Choline/pharmacology , Kidney/drug effects , Mercury/toxicity , Mitochondria/drug effects , Animals , Creatine/metabolism , Interleukin-1/metabolism , Interleukin-6/metabolism , Kidney/metabolism , Kidney/pathology , Kidney Function Tests , Male , Membrane Potentials/drug effects , Mitochondria/metabolism , Mitochondria/pathology , Oxidation-Reduction , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism
11.
Biochem Cell Biol ; 93(3): 185-91, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25589288

ABSTRACT

Hyperthyroidism represents an increased risk factor for cardiovascular morbidity, especially when the heart is subjected to an ischemia/reperfusion process. The aim of this study was to explore the possible protective effect of the nucleotide citicoline on the susceptibility of hyperthyroid rat hearts to undergo reperfusion-induced damage, which is associated with mitochondrial dysfunction. Hence, we analyzed the protective effect of citicoline on the electrical behavior and on the mitochondrial function in rat hearts. Hyperthyroidism was established after a daily i.p. injection of triiodothyronine (at 2 mg/kg of body weight) during 5 days. Thereafter, citicoline was administered i.p. (at 125 mg/kg of body weight) for 5 days. In hyperthyroid rat hearts, citicoline protected against reperfusion-induced ventricular arrhythmias. Moreover, citicoline maintained the accumulation of mitochondrial Ca(2+), allowing mitochondria to reach a high transmembrane electric gradient that protected against the release of cytochrome c. It also preserved the activity of the enzyme aconitase that inhibited the release of cytokines. The protection also included the inhibition of oxidative stress-induced mDNA disruption. We conclude that citicoline protects against the reperfusion damage that is found in the hyperthyroid myocardium. This effect might be due to its inhibitory action on the permeability transition in mitochondria.


Subject(s)
Cardiotonic Agents/pharmacology , Cytidine Diphosphate Choline/pharmacology , Heart/drug effects , Hyperthyroidism/physiopathology , Mitochondria, Heart/drug effects , Aconitate Hydratase/metabolism , Animals , Calcium/metabolism , DNA, Mitochondrial/metabolism , Hyperthyroidism/chemically induced , Hyperthyroidism/complications , Mitochondria, Heart/metabolism , Myocardial Reperfusion , Myocardial Reperfusion Injury/prevention & control , Rats , Superoxide Dismutase/metabolism , Triiodothyronine/adverse effects
12.
Cell Biol Int ; 38(3): 287-95, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23765583

ABSTRACT

Chemical modification of primary amino groups of mitochondrial membrane proteins by the fluorescent probe fluorescamine induces non-specific membrane permeabilisation. Titration of the lysine ϵ-amino group promoted efflux of accumulated Ca(2+), collapse of transmembrane potential and mitochondrial swelling. Ca(2+) release was inhibited by cyclosporin A. Considering the latter, we assumed that fluorescamine induces permeability transition. Carboxyatractyloside also inhibited the reaction. Using a polyclonal antibody for adenine nucleotide translocase, Western blot analysis showed that the carrier appeared labelled with the fluorescent probe. The results point out the importance of the ϵ-amino group of lysine residues, located in the adenine nucleotide carrier, on the modulation of membrane permeability, since its blockage suffices to promote opening of the non-specific nanopore.


Subject(s)
Cell Membrane Permeability/drug effects , Fluorescamine/pharmacology , Lysine/metabolism , Membrane Potentials/drug effects , Mitochondrial ADP, ATP Translocases/metabolism , Animals , Atractyloside/analogs & derivatives , Atractyloside/metabolism , Calcium/metabolism , Cell Membrane Permeability/physiology , Ion Transport/drug effects , Ion Transport/physiology , Male , Membrane Potentials/physiology , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondrial ADP, ATP Translocases/drug effects , Mitochondrial Swelling/drug effects , Mitochondrial Swelling/physiology , Rats , Rats, Wistar
13.
Acta Pharmacol Sin ; 35(11): 1364-74, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25263337

ABSTRACT

AIM: Metabolic syndrome (MS) and aging are low-grade systemic inflammatory conditions, and inflammation is a key component of endothelial dysfunction. The aim of this study was to investigate the effects of non-steroidal anti-inflammatory drugs (NSAIDs) upon the vascular reactivity in aging MS rats. METHODS: MS was induced in young male rats by adding 30% sucrose in drinking water over 6, 12, and 18 months. When the treatment was finished, the blood samples were collected, and aortas were dissected out. The expression of COX isoenzymes and PLA2 in the aortas was analyzed using Western blot analysis. The contractile responses of aortic rings to norepinephrine (1 µmol/L) were measured in the presence or absence of different NSAIDs (10 µmol/L for each). RESULTS: Serum levels of pro-inflammatory cytokines (IL-6, TNF-α, and IL-1ß) in control rats were remained stable during the aging process, whereas serum IL-6 in MS rats were significantly increased at 12 and 18 months. The levels of COX isoenzyme and PLA2 in aortas from control rats increased with the aging, whereas those in aortas from MS rats were irregularly increased with the highest levels at 6 months. Pretreatment with acetylsalicylic acid (a COX-1 preferential inhibitor), indomethacin (a non-selective COX inhibitor) or meloxicam (a COX-2 preferential inhibitor) decreased NE-induced contractions of aortic rings from MS rats at all the ages, with meloxicam being the most potent. Acetylsalicylic acid also significantly reduced the maximum responses of ACh-induced vasorelaxation of aortic rings from MS rats, but indomethacin and meloxicam had no effect. CONCLUSION: NSAIDs can directly affect vascular responses in aging MS rats. Understanding the effects of NSAIDs on blood vessels may improve the treatment of cardiovascular diseases and MS in the elders.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aorta/drug effects , Metabolic Syndrome/drug therapy , Vasoconstriction/drug effects , Vasodilation/drug effects , Age Factors , Animals , Aorta/metabolism , Aorta/physiopathology , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Inflammation Mediators/blood , Interleukin-1beta/blood , Interleukin-6/blood , Male , Membrane Proteins/metabolism , Metabolic Syndrome/blood , Metabolic Syndrome/chemically induced , Metabolic Syndrome/physiopathology , Phospholipases A2/metabolism , Rats, Wistar , Sucrose , Time Factors , Tumor Necrosis Factor-alpha/blood , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
14.
Biomed Pharmacother ; 162: 114649, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37023620

ABSTRACT

Epidemiological studies imply there is a higher risk of cardiovascular disease in menopausal women. Some explanations suggest a lack of estrogens as the cause, but estrogens do not disappear completely and are just transformed into different products called estrogenic degradation metabolites (EDMs). When estrogens are metabolized, reactive oxygen species (ROS) increase, causing DNA damage and increasing oxidative stress. These conditions are associated to neurodegenerative diseases and different types of cancer. However, their effect on the cardiovascular system remains unknown. This paper compares estrogenic metabolite levels in serum from post-menopausal women with cardiovascular risk (CAC>1) and with establish cardiovascular disease (CVD), against levels in healthy women (Ctrl). Sample sera were obtained from the Genetics of Atherosclerotic Disease (GEA) Mexican Study. Serum levels of eleven estrogenic metabolites were quantified by High performance liquid chromatography (HPLC) and oxidative stress markers such as ROS, lipoperoxidation levels (TBARS), total antioxidant capacity (TAC), super oxide dismutase activity (SOD) and cytokine levels were evaluated. 8-hydroxy-2-deoxyguanosine (8-OHdG) was also determined as a marker of nuclear damage.There were significant differences between serum levels of some EDMs in CAC> 1 and CVD vs. serum levels in Ctrl women. Results also revealed an increase in oxidative stress and a diminished capacity to manage oxidative stress. These findings provide an overview, and suggest that some estrogenic metabolites may be associated with an increased risk of CVD in menopausal women. However, additional studies are needed to evaluate the impact of these EDMs directly on cardiovascular function.


Subject(s)
Cardiovascular Diseases , Heart Diseases , Female , Humans , Estrogens/metabolism , Cardiovascular Diseases/etiology , Reactive Oxygen Species , Menopause
15.
J Bioenerg Biomembr ; 43(6): 757-64, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22108703

ABSTRACT

Permeability transition was examined in heart mitochondria isolated from neonate rats. We found that these mitochondria were more susceptible to Ca(2+)-induced membrane leakiness than mitochondria from adult rats. In K(+) containing medium, at 25 °C, mitochondria were unable to accumulate Ca(2+). Conversely, in Na(+) containing medium, mitochondria accumulated effectively Ca(2+). At 15 °C mitochondria accumulated Ca(2+) regardless of the presence of K(+). Kinetics of Ca(2+) accumulation showed a similar Vmax as that of adult mitochondria. Lipid milieu of inner membrane contained more unsaturated fatty acids than adult mitochondria. Aconitase inhibition and high thiobarbituric acid-reactive substances (TBARS) indicate that oxidative stress caused mitochondrial damage. In addition, proteomics analysis showed that there is a considerable diminution of succinate dehydrogenase C and subunit 4 of cytochrome oxidase in neonate mitochondria. Our proposal is that dysfunction of the respiratory chain makes neonate mitochondria more susceptible to damage by oxidative stress.


Subject(s)
Calcium/pharmacology , Mitochondria, Heart/metabolism , Mitochondrial Membranes/metabolism , Oxidative Stress/drug effects , Animals , Electron Transport/drug effects , Permeability/drug effects , Potassium/metabolism , Rats
16.
Can J Physiol Pharmacol ; 89(12): 899-910, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22115172

ABSTRACT

The kidneys are organs that can be severely impaired by metabolic syndrome (MS). This is characterized by the association of various pathologies such as hypertension, dyslipidemia, and type-2 diabetes. Glycine, a nonessential amino acid, is known to possess various protective effects in the kidney, such as a decrease in the deterioration of renal function and a reduction of the damage caused by hypoxia. In a rat model of MS, the effect of glycine on the cyclooxygenase (COX) pathway of arachidonic acid (AA) metabolism was studied in isolated perfused kidney. MS was induced in Wistar rats by feeding them a 30% sucrose solution for 16 weeks. The addition of 1% glycine to their drinking water containing 30% sucrose, for 8 weeks, reduced high blood pressure, triglyceride levels, insulin concentration, homeostatis model assessment (HOMA) index, albuminuria, AA concentration in kidney homogenate, renal perfusion pressure, prostaglandin levels, PLA2 expression, and COX isoform expression, compared with MS rats that did not receive the glycine supplement. Glycine receptor expression decreased significantly with MS, but glycine treatment increased it. The results suggest that in the MS model, 1% glycine treatment protects the kidney from damage provoked by the high sucrose consumption, by acting as an anti-inflammatory on the COX pathway of AA metabolism in kidney.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Arachidonic Acid/metabolism , Glycine/pharmacology , Kidney/drug effects , Metabolic Syndrome/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Animals , Blood Pressure/drug effects , Body Weight/drug effects , Disease Models, Animal , Kidney/metabolism , Male , Metabolic Syndrome/chemically induced , Metabolic Syndrome/physiopathology , Rats, Wistar , Signal Transduction
17.
Biology (Basel) ; 10(7)2021 Jul 16.
Article in English | MEDLINE | ID: mdl-34356526

ABSTRACT

Our work evaluated cardiac function and mitochondrial bioenergetics parameters in hearts from male Wistar rats subjected to the UUO model during 28 days of progression. We measured markers of kidney damage and inflammation in plasma and renal fibrosis by histological analysis and Western blot. Cardiac function was evaluated by echocardiography and proteins involved in cardiac damage by Western blot. Oxygen consumption and transmembrane potential were monitored in cardiac mitochondria using high-resolution respirometry. We also determined the activity of ATP synthase and antioxidant enzymes such as glutathione peroxidase, glutathione reductase, and catalase. Our results show that, although renal dysfunction is established in animals subjected to ureteral obstruction, cardiac function is maintained along with mitochondrial function and antioxidant enzymes activity after 28 days of injury evolution. Our results suggest that renocardiac syndrome might develop but belatedly in obstruction-induced renal damage, opening the opportunity for treatment to prevent this condition.

18.
J Bioenerg Biomembr ; 42(5): 381-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20725852

ABSTRACT

Ca²+ loading in mitochondria promotes the opening of a non-selective transmembrane pathway. Permeability transition is also associated with the interaction of cyclophilin D at the internal surface of the non-specific transmembrane pore. This interaction is circumvented by cyclosporin A and ADP. Our results show that, in the absence of ADP, liver mitochondria were unable to retain Ca²+, they underwent a fast and large amplitude swelling, as well as a rapid collapse of the transmembrane potential. In contrast, in the absence of ADP, kidney mitochondria retained Ca²+, swelling did not occur, and the collapse of the membrane potential was delayed. Ca²+ efflux was reversed by the addition of ADP and cyclosporin A. Our findings indicate that the differences between liver and kidney mitochondria are due to the low association of cyclophilin D to the ADP/ATP carrier found in kidney mitochondria as compared to liver mitochondria.


Subject(s)
Adenosine Diphosphate/metabolism , Calcium/metabolism , Kidney/metabolism , Liver/metabolism , Mitochondria/metabolism , Animals , Peptidyl-Prolyl Isomerase F , Cyclophilins/metabolism , Cyclosporine/metabolism , Membrane Potential, Mitochondrial/physiology , Rats , Spectrophotometry
19.
Cell Calcium ; 91: 102267, 2020 11.
Article in English | MEDLINE | ID: mdl-32920522

ABSTRACT

Autonomous Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation induces abnormal diastolic Ca2+ leak, which leads to triggered arrhythmias in a wide range of cardiovascular diseases, including diabetic cardiomyopathy. In hyperglycemia, Ca2+ handling alterations can be aggravated under stress conditions via the ß-adrenergic signaling pathway, which also involves CaMKII activation. However, little is known about intracellular Ca2+ handling disturbances under ß-adrenergic stimulation in cardiomyocytes of the prediabetic metabolic syndrome (MetS) model with obesity, and the participation of CaMKII in these alterations. MetS was induced in male Wistar rats by administering 30 % sucrose in drinking water for 16 weeks. Fluo 3-loaded MetS cardiomyocytes exhibited augmented diastolic Ca2+ leak (in the form of spontaneous Ca2+ waves) under basal conditions and that Ca2+ leakage was exacerbated by isoproterenol (ISO, 100 nM). At the molecular level, [3H]-ryanodine binding and basal phosphorylation of cardiac ryanodine receptor (RyR2) at Ser2814, a CaMKII site, were increased in heart homogenates of MetS rats with no changes in RyR2 expression. These alterations were not further augmented by Isoproterenol. SERCA pump activity was augmented 48 % in MetS hearts before ß-adrenergic stimuli, which is associated to augmented PLN phosphorylation at T17, a target of CaMKII. In MetS hearts. CaMKII auto-phosphorylation (T287) was increased by 80 %. The augmented diastolic Ca2+ leak was prevented by CaMKII inhibition with AIP. In conclusion, CaMKII autonomous activation in cardiomyocytes of MetS rats with central obesity significantly contributes to abnormal diastolic Ca2+ leak, increasing the propensity for ß-adrenergic receptor-driven lethal arrhythmias.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Calcium/metabolism , Diastole , Metabolic Syndrome/metabolism , Myocytes, Cardiac/metabolism , Receptors, Adrenergic, beta/metabolism , Animals , Calcium-Binding Proteins/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/antagonists & inhibitors , Diastole/drug effects , Isoproterenol/pharmacology , Male , Metabolic Syndrome/pathology , Myocytes, Cardiac/drug effects , Peptides/pharmacology , Phosphorylation/drug effects , Rats, Wistar , Ryanodine Receptor Calcium Release Channel/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism
20.
Biochem Res Int ; 2020: 5253108, 2020.
Article in English | MEDLINE | ID: mdl-33489376

ABSTRACT

Mitochondrial permeability transition is characterized by the opening of a transmembranal pore that switches membrane permeability from specific to nonspecific. This structure allows the free traffic of ions, metabolites, and water across the mitochondrial inner membrane. The opening of the permeability transition pore is triggered by oxidative stress along with calcium overload. In this work, we explored if oxidative stress is a consequence, rather than an effector of the pore opening, by evaluating the interaction of agaric acid with the adenine nucleotide translocase, a structural component of the permeability transition pore. We found that agaric acid induces transition pore opening, increases the generation of oxygen-derived reactive species, augments the oxidation of unsaturated fatty acids in the membrane, and promotes the detachment of cytochrome c from the inner membrane. The effect of agaric acid was inhibited by the antioxidant tamoxifen in association with decreased binding of the thiol reagent eosin-3 maleimide to the adenine nucleotide translocase. We conclude that agaric acid promotes the opening of the pore, increasing ROS production that exerts oxidative modification of critical thiols in the adenine nucleotide translocase.

SELECTION OF CITATIONS
SEARCH DETAIL